期刊文献+

瑞巴派特在大鼠痛风性关节炎急性发作中的作用 被引量:3

Effect of rebamipide on the acute gouty arthritis in rats induced by monosodium urate crystals
下载PDF
导出
摘要 目的:了解瑞巴派特(rebamipide)在预防尿酸盐晶体诱导的大鼠痛风性关节炎急性发作中的作用。方法:42只雄性大鼠按随机表法分为3组(n=14),以尿酸盐晶体制备大鼠急性痛风性踝关节炎模型,A组口服瑞巴派特治疗,B组口服秋水仙碱治疗,C组口服安慰剂治疗,观察各组踝关节的临床表现及病理变化,检测大鼠血清中白细胞介素(interleukin,IL)-1β、IL-6、IL-10、肿瘤坏死因子(tumor necrosis factor,TNF)-α水平。结果:C组大鼠关节炎的临床评分、肿胀指数在24 h达到最大值,后逐渐下降,72 h基本恢复正常。造模24 h后,C组的临床评分明显高于A组和B组[2(1~3)vs.0(0~1)vs.1(0~2)],差异有统计学意义(P=0.008);C组的肿胀指数明显高于A组和B组[0.36(0.16~0.52)vs.0.11(0~0.20)vs.0.12(0~0.16)],差异有统计学意义(P=0.005);组织学上,C组的滑膜组织中有大量中性粒细胞浸润[5分量表评分为4(2~4)],A组[1(0~2)]与B组[1(0~2)]未见明显炎性细胞浸润,差异有统计学意义(P<0.001)。造模24 h后,C组大鼠血清中IL-1β、IL-6、IL-10和TNF-α水平明显高于A组和B组[IL-1β:(41.86±5.72)vs.(27.35±7.47)vs.(27.76±5.28)ng/L;IL-6:(1575.55±167.11)vs.(963.53±90.22)vs.(964.08±99.31)ng/L;IL-10:(37.96±3.76)vs.(21.68±4.83)vs.(16.20±2.49)ng/L;TNF-α:(21.32±1.34)vs.(15.82±2.54)vs.(17.35±7.47)μg/L],差异均有统计学意义(P<0.001)。结论:瑞巴派特在大鼠痛风模型中对痛风性关节炎急性发作起预防保护作用。 Objective:To investigate the role of rebamipide in the treatment of acute gout arthritis rats induced by monosodium urate(MSU)crystal.Methods:Forty-two male rats were randomly divided into three groups(n=14).Group A was treated with oral rebamipide,group B with oral colchicine,and group C with oral placebo.The rats were monitored for the induction of arthritis with clinical manifestations and pathological changes,and the levels of interleukin(IL)-1β、IL-6、IL-10,and tumor necrosis factor(TNF)-αin serum were measured.Results:In group C,the clinical score and swelling index reached the maximum in 24 h,and then gradually decreased to 72 h.After 24 h of model induced,the clinical scores in group C were significantly higher than those in group A and group B[2(1-3)vs.0(0-1)vs.1(0-2),P<0.01],the swelling indexes in group C were significantly higher than those in group A and group B[0.36(0.16-0.52)vs.0.11(0-0.20)vs.0.12(0-0.16),P<0.01].Histologically,after 24 h of model induced,there was a large number of neutrophil infiltration in the synovium of group C[scale score:4(2-4)],and there was no significant inflammatory cell infiltration in group A[1(0-2)]and group B[1(0-2)],the difference was statistically significant(P<0.001).After 24 h of model induced,the levels of IL-1β,IL-6,IL-10,and TNF-αin serum of group C were significantly higher than those in group A and B[IL-1β:(41.86±5.72)vs.(27.35±7.47)vs.(27.76±5.28)ng/L,IL-6:(1575.55±167.11)vs.(963.53±90.22)vs.(964.08±99.31)ng/L,IL-10:(37.96±3.76)vs.(21.68±4.83)vs.(16.20±2.49)ng/L,TNF-α:(21.32±1.34)vs.(15.82±2.54)vs.(17.35±7.47)μg/L,P<0.001].Conclusion:Rebamipide has a protective effect on acute gout arthritis rats induced by MUS crystals.
作者 王贵红 左婷 李然 左正才 WANG Gui-hong;ZUO Ting;LI Ran;ZUO Zheng-cai(Department of Rheumatology and Immunology,Anqing Hospital of Anhui Medical University,Anqing 246000,Anhui,China)
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2021年第4期716-720,共5页 Journal of Peking University:Health Sciences
基金 安庆市医疗卫生科技计划项目(2018Z2003)。
关键词 痛风性关节炎 瑞巴派特 动物模型 大鼠 Gouty arthritis Rebamipide Animal models Rats
  • 相关文献

参考文献2

二级参考文献77

  • 1关宝生,白雪,王艳秋,尹相林,李若男,周宪君,徐辉,杜文彦,邱洪斌.痛风/高尿酸血症患者生活习惯的危险因素[J].中国老年学杂志,2014,34(2):455-457. 被引量:60
  • 2方卫纲,黄晓明,王玉,陈伟,朱卫国,陈嘉林,曾学军.北京地区部分人群痛风的流行病学调查[J].基础医学与临床,2006,26(7):781-785. 被引量:48
  • 3罗彦玲,邓丽丽,王红,李心治.痛风的遗传度及遗传方式的研究[J].中华内分泌代谢杂志,1997,13(2):126-127. 被引量:19
  • 4Richette P,Bardin T.Gout[J].Lancet,375(9711): 318-328.
  • 5Lee SJ,Hirsch JD,Terkeltaub R,et al.Perceptions of disease and health-related quality of life among patients with gout[J].Rheumatology,2009,48(5): 582-586.
  • 6Nan H,Qiao Q,Dong Y,et al.The prevalence of hyperuricemia in a population of the coastal city of Qingdao,China[J].J Rheumatol,2006,33(7):1346-1350.
  • 7Miao Z,Li C,Chen Y,et al.Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China[J].J Rheumatol,2008,35(9): 1859-1864.
  • 8Wallace KL,Riedel AA,Joseph-Ridge N,et al.Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population[J].J Rheumatol,2004,31(8):1582-1587.
  • 9Juraschek SP,Miller ER,Gelber AC.Body mass index,obesity,and prevalent gout in the United States in 1988-1994 and 2007-2010[J].Arthritis Care Res (Hoboken),2013,65(1): 127-132.
  • 10Kuo CF,Grainge MJ,Mallen C,et al.Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study[J/OL].Ann Rheum Dis,2014.[2014-08-01].http://ard.bmj.com/content/early/2014/01/03/annrheumdis-2013-204463.long.[published online ahead of print January 15,2014].

共引文献678

同被引文献48

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部